Conflicts of Interest in Clinical Trials

Presented by Vera Hassner Sharav
14th Tri-Service Clinical Investigation Symposium
Sponsored by The U.S. Army Medical Department and The Henry M. Jackson Foundation for the Advancment of Military Medicine

The cornerstone of public trust in medical research is the integrity of academic institutions and the expectation that universities, which rely on public funding, have a responsibility to serve the public good. Financial conflicts of interest affect millions of American people – those who are subjects of clinical trials testing new drugs and those who are prescribed drugs after their approval.

InfoMail for February 26, 2002

  AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav February 26, 2002  FYI Severe Side Effects Reported forClozaril Drug induced inflammation of the heart (myocarditis) isone of several potentially fatal side effects of the so-called ‘atypical’antipsychotic…

2000 Study by Merck Showed Vioxx Risk: Results Not Given to FDA – Star Ledger

2000 Study by Merck Showed Vioxx Risk: Results Not Given to FDA – Star Ledger Sun, 3 Jul 2005 News reports reveal that Merck failed to disclose Vioxx lethal effects to the FDA. Sheldon Krimsky, a science policy expert at Tufts University states: “if there was evidence the drug was…